Here, we demonstrated that inhibition of tryptophan uptake by knockdown of SLC7A5 in the lung cancer cell caused subsequent decrease of cellular level of NAD, along with attenuation of glycolytic activity. The gene discussed is SLC7A5; the disease is lung carcinoma.